Evidence map›Paper›PMID 42079139›Full record

ArticlebioRxiv : the preprint server for biology2026

GNOMES: an integrated framework for genome-wide normalization and differential binding analysis of CUT&RUN and ChIP-seq data.

Thomas Roule, Naiara Akizu

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas RoulePerelman Center for Cellular and Molecular Therapeutics and Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-6661-9357
Naiara AkizuPerelman Center for Cellular and Molecular Therapeutics and Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-9222-6960

Funding

The role of EZH1 in neuronal differentiation and neurological disordersR01NS119699 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Naiara Akizu · 2022 to 2026
$2.8M
NINDS NIH HHS R01 NS119699
6 · The paper itself

Abstract

Background: Despite their use, quantitative comparison of epigenomic datasets such as ChIP-seq and CUT&RUN remains challenging, particularly due to difficulties in signal normalization across samples and conditions. Normalization solely based on sequencing depth is often insufficient due to the high variability in signal-to-noise ratios across samples, even from a same experiment. While exogeneous spike-in normalization can address some issues, robust spike-in controls are not always available, and may introduce additional experimental burden and computational complexity. Furthermore, normalization and differential binding analysis are typically performed using separate bioinformatics tools. Indeed, most differential analysis frameworks operate on raw count matrices, preventing users from visually inspecting normalized signal tracks and evaluating how normalization influences the results. To overcome these challenges, we developed Results: Conclusions:

Indexed as

Bioinformatics softwareChIP-seqCUT&RUNCUT&TAGDifferential BindingEpigenomicNormalization

Identifiers

PMID42079139
PMCPMC13131678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.